Vladonix
Also known as: Thymus peptide bioregulator · Vladonix AA
A thymus-derived peptide bioregulator studied in Russian research for immune-related markers in aging.
Vladonix at a glance
| Name | Vladonix |
|---|---|
| Also known as | Thymus peptide bioregulator, Vladonix AA |
| Category | Immune support |
| Type | Peptide |
| Sequence | Tissue-specific peptide fraction |
| Typical dose | Commonly cited around 1-3 mg per short course |
| Frequency | Short cyclical courses in the discussed protocols |
| Route | Subcutaneous or intramuscular injection (research); oral capsule forms also marketed |
| Half-life | Not well established. |
Overview
Vladonix is presented as a peptide preparation derived from thymus tissue, positioned within the bioregulator framework as an immune-oriented compound. It is discussed for its proposed effects on immune-cell activity and immune resilience during aging, a role broadly parallel to earlier thymic peptide work. The evidence remains concentrated in the originating research group, is largely older and non-Western, and has not been widely reproduced in mainstream immunology literature.
How it’s thought to work
- Proposed to act as a thymus-specific peptide bioregulator influencing gene expression in immune tissue.
- Studied for effects on T-cell and broader immune-cell activity.
- Mechanisms overlap with claims made for other thymic peptides but are not independently well established.
Researched uses
- Immune support in aging models
- General immune-resilience research interest
- Cited in longevity-peptide and thymus-function discussions
Commonly cited protocol
| Typical dose | Commonly cited around 1-3 mg per short course |
|---|---|
| Frequency | Short cyclical courses in the discussed protocols |
| Route | Subcutaneous or intramuscular injection (research); oral capsule forms also marketed |
| Notes | Typically described in cycles in the source literature. |
Reconstitution
Commonly a 5-10 mg vial; reconstitute with bacteriostatic water and use the calculator for units.
Vladonix dosage calculator
The calculator below is pre-filled with Vladonix’s commonly cited vial size and dose. Adjust the vial amount, bacteriostatic water, or dose to match your own vial — it will show the exact insulin-syringe units to draw, the concentration, and how many doses the vial holds.
Add 2 mL of bacteriostatic water to your 10 mg vial. That gives you about 5 doses of 2 mg. For each dose, draw 40 units into a 100-unit insulin syringe.
See the full Vladonix dosing chart (units for every dose & water amount), or open the full peptide calculator →
Cautions
- Not FDA-approved; a research compound, not an approved immune therapy.
- The evidence base is limited, older, and largely non-Western, and has not been widely replicated.
- Purity of research-grade or tissue-extract material varies by source.
- Immune conditions should be managed with a qualified clinician rather than self-directed peptide use.
Vladonix FAQ
What is Vladonix?
A thymus-derived peptide bioregulator studied in Russian research for immune-related markers in aging.
How does Vladonix work?
Proposed to act as a thymus-specific peptide bioregulator influencing gene expression in immune tissue. Studied for effects on T-cell and broader immune-cell activity. Mechanisms overlap with claims made for other thymic peptides but are not independently well established.
What is Vladonix used for?
Immune support in aging models; General immune-resilience research interest; Cited in longevity-peptide and thymus-function discussions.
What is a typical Vladonix dose?
Commonly cited around 1-3 mg per short course, Short cyclical courses in the discussed protocols, Subcutaneous or intramuscular injection (research); oral capsule forms also marketed. This is a commonly cited figure for context only, not medical advice.
How do you reconstitute Vladonix?
Commonly a 5-10 mg vial; reconstitute with bacteriostatic water and use the calculator for units.
What is the half-life of Vladonix?
Not well established.